IG Resources
IG News
Keeping you abreast of the latest developments in the IG industry and community, the following are a few articles which may be of interest to you and your patients. Please click the link to be redirected to the full article and news source:
Shire Announces U.S. FDA Approval of CUVITRU[TM] [Immune Globulin Subcutaneous (Human), 20% Solution] Treatment for Primary Immunodeficiency
September, 2016
CSL Plasma Raises Over $118,000 for the Immune Deficiency Foundation
July, 2016
Kedrion 10% Safe and Effective for Treating PI
January, 2016
GSP, Italian partners file ‘bubble boy’ gene therapy in EU
May, 2015
Refer a NuFACTOR patient
Talk with us today about referring a NuFACTOR patient. Call us at (800) 323-6832 and we will be more than happy to help you through the process.
